Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis. - Harjunpää H; Blake SJ; Ahern E; Allen S; Liu J; Yan J; Lutzky V; Takeda K; Aguilera AR; Guillerey C; Mittal D; Li XY; et al. (Oncoimmunology, 2018)